<DOC>
	<DOCNO>NCT01424046</DOCNO>
	<brief_summary>This study pilot 2-armed , randomize , open label , clinical trial evaluate effectiveness basal approach diabetes management compare current standard treatment ( regular/NPH ) . Patients see Association Rwandaise de Diabetiques ( ARD ) invite participate study consent obtain investigation team . This continue 40 patient enrolled time recruitment start provincial hospital , 10 participant recruit . Participants consent 1 ) Randomization basal current insulin treatment arm 2 ) Permission use clinical data research.Participants follow every six month period 24 month . The first 6 month wash period participant randomise ( 1/1 ) treatment 6 month visit .</brief_summary>
	<brief_title>Health Care Type 1 Diabetes Developing World</brief_title>
	<detailed_description>All participant provide consent form ( translated native language Kinyarwandan ) investigator consent obtain participant age 18 old parents/guardians 18 year . For aged 14 - 17 year child assent obtain . For unable read consent form patient advocate read form answer question potential participant may . Each person time space review study information inform participation completely voluntary continue receive normal care wish participate . At visit follow data extract clinical file research assistant supervision Prof Kakoma : At 6 monthly visit ( V1-V4 ) , data participant ' regular clinical visit ( base annual evaluation form Life For Child program ) extract . This include HbA1c microalbuminuria data collection , well documentation : insulin regimen , incident severe hypo- hyper-glycemia , symptom hyperglycemia , current school level , number school day miss due diabetes , self-rating diabetes control , height , weight , blood pressure , basic neurological examination ( vibratory sensation great toe monofilament test ) . Information abstract research assistant National University Rwanda ( NUR ) , education management function carry nurse ARD train Drs Orchard Edidin . Each enrol participant follow six month period post enrollment current treatment regimen impact enrol study rather effect treatment , assess . All participant supply glucose meter sufficient strip test daily . These result also make available reviewed ARD staff use dose adjustment .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Type 1 diabetes treat Association Rwandese de Diabetiques Resident Rwanda life expectancy less three year require additional diabetes therapy beyond scope trial</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>24 Years</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>type 1 diabetes</keyword>
	<keyword>basal insulin</keyword>
	<keyword>develop world</keyword>
	<keyword>comparative effectiveness</keyword>
</DOC>